Overview
Share price and charges
Share class
KTicker
BGUKXNAV
6.11% change
0.00%Management fee
0.67%Other expenses
7.41%Gross expense ratio
8.08%Fee waiver
-7.26%Net expense ratio
0.82%Fund facts
Fund launch date
May 5, 2021
Fund size
$2.0m
Benchmark
S&P Composite 1500 Index
Current number of holdings
46
Active share
100%*
Annual turnover
17%
Style
Growth
Guideline number of holdings
40-75
*Relative to the S&P Composite 1500 Index.
Source: Baillie Gifford & Co and relevant underlying index provider(s).
Portfolio characteristics
The fund's characteristics compared to the index.
As at October 31, 2024
Fund | S&P Composite 1500 Index | |
---|---|---|
Market cap (weighted average) | $6.11bn | $913.75bn |
Price / Book | 4.61 | 4.79 |
Price / Earnings (12 months forward) | 34.22 | 20.37 |
Earnings growth (5 year historic) | -24.82% | 8.53% |
Return on equity (12 months forward) | -0.81% | 23.26% |
Standard deviation (trailing 3 years) | 27.33% | 21.36% |
Beta | 1.55 | N/A |
Source: Baillie Gifford & Co, FactSet, Revolution, and relevant underlying index provider(s).
Beta is in comparison to S&P Composite 1500 Index.
A full glossary of definitions can be viewed at the bottom of this page.
Meet the managers
Risks
The most significant risks of an investment in the Baillie Gifford U.S. Discovery Fund are: Small- and Medium- Capitalization Securities Risk, Growth Stock Risk, Investment Style Risk, Long-Term Investment Strategy Risk and Geographic Focus Risk. The shares of small and medium -capitalization companies can be more volatile than larger companies. This can be more evident during market downturns as they may have potentially reduced liquidity and shorter operating histories. The prices of growth stocks can be based largely on expectations of future earnings and can decline significantly in reaction to negative news. The Fund is managed on a bottom up basis and stock selection is likely to be the main driver of investment returns. Returns are unlikely to track the movements of the benchmark. The Fund is managed on a long-term outlook, meaning that the Fund managers look for investments that they think will make returns over a number of years, rather than over shorter time periods. The Fund focuses on investments in the US, meaning it may offer less diversification and be more volatile than other funds. Other Fund risks include: Conflicts of Interest Risk, Equity Securities Risk, Environmental, Social and Governance Risk, Focused Investment Risk, Government and Regulatory Risk, Information Technology Risk, Initial Public Offering Risk, Liquidity Risk, Market Disruption and Geopolitical Risk, Market Risk, New and Smaller-Sized Funds Risk, Service Provider Risk and Valuation Risk.
Index disclaimer
The S&P 500, S&P Global SmallCap and Dow Jones Islamic Market World (index) are products of S&P Dow Jones Indices LLC or its affiliates ("SPDJI"), and has been licensed for use by Baillie Gifford & Co. S&P®, S&P 500®, US 500, The 500, iBoxx®, iTraxx® and CDX® are trademarks of S&P Global, Inc. or its affiliates ("S&P"); Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC ("Dow Jones"); and these trademarks have been licensed for use by SPDJI and sublicensed for certain purposes by Baillie Gifford & Co. Baillie Gifford & Co Product(s) are not sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, their respective affiliates and none of such parties make any representation regarding the advisability of investing in such product(s) nor do they have any liability for any errors, omissions, or interruptions of the S&P 500, S&P Global Small Cap and Dow Jones Islamic Market World Index.
London Stock Exchange Group plc and its group undertakings (collectively, the “LSE Group”). © LSE Group 2020. FTSE Russell is a trading name of certain of the LSE Group companies. Russell® is/are a trade mark(s) of the relevant LSE Group companies and is/are used by any other LSE Group company under license. “TMX®” is a trade mark of TSX, Inc. and used by the LSE Group under license. All rights in the FTSE Russell indexes or data vest in the relevant LSE Group company which owns the index or the data. Neither LSE Group nor its licensors accept any liability for any errors or omissions in the indexes or data and no party may rely on any indexes or data contained in this communication. No further distribution of data from the LSE Group is permitted without the relevant LSE Group company’s express written consent. The LSE Group does not promote, sponsor or endorse the content of this communication.”
The Baillie Gifford Mutual Funds are distributed by Baillie Gifford Funds Services LLC. Investors should carefully consider the objectives, risks, charges and expenses of the Funds before investing. This information and other information about the Funds can be found in the prospectus and the summary prospectus. For a prospectus and summary prospectus please go to the Documents section on this page. Please carefully read the Fund’s prospectus and related documents before investing.
Definitions
Active share
A measure of the Fund's overlap with the benchmark. An active share of 100 indicates no overlap with the benchmark and an active share of zero indicates a portfolio that tracks the benchmark.
Annual turnover
Turnover is calculated as the smaller figure of either purchases or sales for the month and dividing it by an average fund market value. Annual Turnover is calculated as the sum of the monthly turnover figures for the 12 month period.
Market cap (weighted average)
The weighted average size of companies represented in the portfolio, denoted by market capitalization.
Price/Book
The weighted average ratio of current share price to last reported company book value per share. This represents a measure of valuation levels.
Price/Earnings (12 months forward)
The weighted average ratio of current share price divided by the 12 month forward earnings per share. This represents a measure of valuation levels.
Earnings growth (5 years historic)
The weighted average growth in earnings per share of current portfolio holdings delivered over the past 5 years, expressed in % per annum. This represents a measure of delivered profits growth for the current holdings in the portfolio or benchmark.
Return on equity (12 months forward)
The weighted average ratio of 12 month forward earnings per share divided by the last reported book value per share. This represents a forward-looking measure of profitability, based on the current holdings of the portfolio or benchmark.
Beta
Beta is a measure of systematic risk, denoting the sensitivity of a fund to the direction of the market. Measures of beta that are significantly higher (lower) than 1.0 indicate a greater (lesser) degree of sensitivity to market direction.
Standard deviation
A measure of the volatility of absolute returns. It is a measure of the dispersion of a set of absolute returns from its mean.
Fund performance
Annualized total returns – as at month end
As at: October 31, 2024
Gross expense ratio | Net expense ratio | 1 month* | 3 months* | Year-to-date* | 1 year | 3 years | Since inception† | |
---|---|---|---|---|---|---|---|---|
Share class K | 8.08% | 0.82% | -1.98% | -1.63% | 4.81% | 37.98% | -18.82% | -15.91% |
S&P Composite 1500 Index | n/a | n/a | -0.94% | 3.30% | 20.12% | 37.54% | 8.66% | 10.54% |
Russell 2500 Growth Index | n/a | n/a | -0.25% | 0.60% | 10.92% | 34.21% | -2.46% | -0.06% |
Annualized total returns – as at quarter end
As at: September 30, 2024
Gross expense ratio | Net expense ratio | 1 year | 3 years | Since inception† | |
---|---|---|---|---|---|
Share class K | 8.08% | 0.82% | 25.51% | -16.70% | -15.78% |
S&P Composite 1500 Index | n/a | n/a | 35.54% | 11.45% | 11.12% |
Russell 2500 Growth Index | n/a | n/a | 25.20% | -0.75% | 0.01% |
Stock level attribution
Top and bottom 5 relative contributors
One month to: October 31, 2024
Holding | Contribution |
---|---|
Trupanion | 1.06% |
Aerovironment | 0.56% |
Axon Enterprise Inc | 0.54% |
Upwork Inc | 0.50% |
Zuora Inc Class A | 0.31% |
TransMedics Group | -2.37% |
NVIDIA | -0.58% |
Twist Bioscience Corp | -0.36% |
Varonis Systems Inc | -0.36% |
Staar Surgical | -0.33% |
Fund portfolio holdings
The list of top 10 holdings that this fund invests in.
As at: October 31, 2024
# | Holding | % of portfolio |
---|---|---|
1 | Axon Enterprise | 8.27 |
2 | AeroVironment | 7.41 |
3 | Freshpet | 4.43 |
4 | Trupanion | 4.42 |
5 | Exact Sciences | 4.08 |
6 | Twist Bioscience | 3.31 |
7 | Novanta | 3.31 |
8 | Varonis Systems | 3.26 |
9 | Doximity | 2.91 |
10 | TransMedics Group | 2.71 |
Holdings by sector
As at: October 31, 2024
# | Sector | Fund % | Benchmark % * | Difference % |
---|---|---|---|---|
1 | Information Technology | 34.22% | 29.94% | 4.28% |
2 | Health Care | 25.96% | 11.08% | 14.88% |
3 | Industrials | 18.80% | 9.54% | 9.26% |
4 | Communication Services | 5.95% | 8.54% | -2.59% |
5 | Consumer Staples | 4.43% | 5.62% | -1.20% |
6 | Financials | 4.42% | 13.74% | -9.32% |
7 | Consumer Discretionary | 3.12% | 10.34% | -7.21% |
8 | Cash | 2.48% | 0.00% | 2.48% |
9 | Materials | 0.62% | 2.50% | -1.88% |
10 | Utilities | 0.00% | 2.52% | -2.52% |
11 | Real Estate | 0.00% | 2.68% | -2.68% |
12 | Energy | 0.00% | 3.50% | -3.50% |
Total | 100.00% | 100.00% |
Holdings by region
As at: October 31, 2024
# | Region | Fund % | Benchmark % * | Difference % |
---|---|---|---|---|
1 | North America | 92.51% | 100.00% | -7.49% |
2 | Emerging Markets | 4.77% | 0.00% | 4.77% |
3 | Cash | 2.48% | 0.00% | 2.48% |
4 | UK | 0.24% | 0.00% | 0.24% |
Total | 100.00% | 100.00% |
Holdings by country
As at: October 31, 2024
# | Country | Fund % | Benchmark % * | Difference % |
---|---|---|---|---|
1 | United States | 92.51% | 100.00% | -7.49% |
2 | Israel | 4.77% | 0.00% | 4.77% |
3 | Cash | 2.48% | 0.00% | 2.48% |
4 | UK | 0.24% | 0.00% | 0.24% |
Total | 100.00% | 100.00% |
Quarterly transactions
Transactions for the three-month period ending 30 September 2024
New purchases
- Cryoport
- Energy Recovery
Complete sales
- American Well Corp Class A
- Pacira BioSciences
- Redfin
Additions
- Exact Sciences
Tax and distributions
The Fund intends to pay dividends to its shareholders at least annually. Distributions will automatically be reinvested in Fund shares unless you submit a request for cash payment with at least ten days prior notice, before the record date for distribution, to the Transfer Agent. The distribution dates will appear on this page alongside the rates once they become available. The dates can be changed by the Officers of the Funds. For more information on Baillie Gifford Funds’ Distributions please see the Statutory Prospectus.
You can find answers to some of our most common questions about tax and distribution for mutual funds in our frequently asked questions document.
Recent distributions
The below table shows the makeup of the most recent distributions paid.
Share class Institutional | Share class K | |
---|---|---|
Income dividends | 0.00000 | 0.00000 |
Short-term capital gains * | 0.00000 | 0.00000 |
Long-term capital gains | 0.00000 | 0.00000 |
Total per share | 0.00000 | 0.00000 |
Ex-dividend date | 12/28/2023 | 12/28/2023 |
Pay date | 12/28/2023 | 12/28/2023 |
Status | Final | Final |
Source: Bank of New York Mellon and Baillie Gifford & Co
*Short-term capital gains are treated as ordinary income for U.S. Federal Income Tax Purposes.
Upcoming distributions
The below table shows the makeup of the most recent distributions paid.
2024
December 27, 2024
December 30, 2024
December 30, 2024
Source: Bank of New York Mellon and Baillie Gifford & Co